At a glance
- Originator LG Chem Investment
- Class Antidepressants; Anxiolytics; Cyclic S oxides; Small molecules; Thiazoles
- Mechanism of Action 5-HT1A serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder
Most Recent Events
- 13 May 2003 No development reported - Preclinical for Anxiety disorders in South Korea (unspecified route)
- 13 May 2003 No development reported - Preclinical for Depression in South Korea (unspecified route)
- 14 Jan 2000 Preclinical development for Anxiety disorders in South Korea (Unknown route)